Pfizer, BioNTech File for Covid-19 Vaccine Approval in Europe

The vaccine could be marketed later this month if the European Medicines Agency concludes that data from trials show sufficient proof of the vaccine's safety.

 
Amazon Makes Mac Commitment, Opening Door to Apple Developers

Tech giants Amazon and Apple are joining forces to support the growing number of companies developing apps and other software for Apple devices.

 
Credit Suisse Taps Lloyds Boss as Next Chairman

Credit Suisse named António Horta-Osório as its next chairman, marking a changing of the guard after a decade under current chairman Urs Rohner punctuated by regulatory fines and scandal.

 
UniCredit's Mustier to Step Down as CEO Over Strategy Rift

Jean Pierre Mustier said it had become clear in recent months that the core pillars of his strategy for the Italian bank "no longer correspond to the board's current thinking."

 
Exxon Slashes Spending, Writes Down Assets

The struggling Texas oil giant is retreating from a plan to increase spending to boost its oil and gas production by 2025 and preparing to slash the book value of its assets by up to $20 billion.

 
Bankruptcy Judge Denies Lenders' Request to Block Sale of New York Sports Clubs Owner

Town Sports, operator of the New York Sports Clubs and Lucille Roberts gym chains, got a green light to move forward with a plan to wrap up a sale of its assets to its lenders and an entity managed by investment banking firm Lepercq de Neuflize & Co.

 
Northwestern Mutual Targets Resources to Black Tech Founders

The Milwaukee-based insurer said earlier this month it started the Northwestern Mutual Black Founder Accelerator, a 12-week program that will be run by Milwaukee-based gener8tor Management LLC, a national startup accelerator. The funding pool and the accelerator are among the latest corporate efforts to connect Black entrepreneurs to venture capital.

 
SBM Offshore Faces Swiss Probe Over Legacy Bribery Allegations

Oil-services firm SBM Offshore is facing an investigation by the Swiss government into bribery allegations that the company said it has already paid hundreds of millions of dollars to resolve in three other countries.

 
Zoom's Pandemic-Fueled Boom Continues

The videoconferencing company posted another quarter of record sales and again lifted its outlook as remote working and distance schooling drags on during the pandemic.

 
Novavax Delays Covid-19 Vaccine Study Over Manufacturing Issues

Novavax has delayed starting a large, decisive clinical trial of its Covid-19 vaccine in the U.S. and Mexico to sometime in the coming weeks due to manufacturing issues, versus an earlier plan to start by the end of November.

(END) Dow Jones Newswires

December 01, 2020 07:15 ET (12:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.